Overview and Scope
Urolithiasis management devices refer to medical tools and devices used in the diagnosis, treatment, and management of urolithiasis, which is the formation of stones (calculi) in the urinary tract. They are primarily used for retrieving, breaking, or aiding the passage of kidney stones, providing minimally invasive treatment options. These devices aim to address the challenges posed by kidney stones by offering efficient and less intrusive solutions for their management.
Sizing and Forecast
The urolithiasis management devices market size has grown strongly in recent years. It will grow from $1.49 billion in 2023 to $1.59 billion in 2024 at a compound annual growth rate (CAGR) of 6.4%. The growth in the historic period can be attributed to a rise in healthcare expenditure and investments in urological care, the aging population leading to a higher incidence of urolithiasis, expansion of healthcare infrastructure in developing regions, regulatory approvals and guidelines promoting the safety and efficacy, and sedentary lifestyles
The urolithiasis management devices market size is expected to see strong growth in the next few years. It will grow to $2.05 billion in 2028 at a compound annual growth rate (CAGR) of 6.6%. The growth in the forecast period can be attributed to increasing awareness about minimally invasive procedures, growing incidence and recurrence of urolithiasis, continued advancements in endoscopic procedures, shift towards outpatient treatments due to cost-effectiveness and reduced hospital stays, and rising patient preference for non-invasive treatment options. Major trends in the forecast period include continued innovation in device technology, emphasis on patient comfort and safety, the integration of robotics and artificial intelligence (AI) in urolithiasis management devices, and advancements in molecular diagnostics and genetic profiling.
Order your report now for swift delivery, visit the link:
Segmentation & Regional Insights
The urolithiasis management devices market covered in this report is segmented –
1) By Product Type: Lithotripters, Ureteroscopes
2) By Treatment Type: Extracorporeal Shock Wave Lithotripsy (ESWL), Intracorporeal Lithotripsy, Percutaneous Nephrolithotomy, Other Treatment Types
3) By End Users: Hospitals, Clinics, Ambulatory Surgical Centers
North America was the largest region in the urolithiasis management devices market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the urolithiasis management devices market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Intrigued to explore the contents? Secure your hands-on sample copy of the report:
https://www.thebusinessresearchcompany.com/sample.aspx?id=15691&type=smp
Major Driver Impacting Market Growth
The rising prevalence of kidney diseases is expected to propel the growth of the urolithiasis management devices market going forward. Kidney disease, also known as renal disease or nephropathy, refers to a condition in which the kidneys are damaged and their function is impaired. The factors driving the rising prevalence of kidney diseases include increased consumption of animal proteins, a lack of physical activity, and rising obesity rates. Urolithiasis management devices enable healthcare professionals to perform precise interventions, relieve obstruction, prevent complications, and improve patient outcomes in cases of urolithiasis-related kidney issues. For instance, in June 2023, according to Kidney Research UK, a UK-based charity organization, the incidence of acute kidney injury is expected to increase from an estimated 615,000 episodes in 2022 to 637,000 by 2033. Therefore, the rising prevalence of kidney diseases is driving the growth of the urolithiasis management devices market.
Key Industry Players
Major companies operating in the urolithiasis management devices market are Medtronic plc, Siemens Healthineers AG, Boston Scientific Corporation, Olympus Corporation, NOVAmedtek, Coloplast Group, Rocamed SAM, DirexGroup, Cook Medical Inc., Karl Storz SE & Co. KG, C. R. Bard Inc., MTS Medical LLC, Richard Wolf GmbH, Wellspect HealthCare, Dornier MedTech GmbH, EDAP TMS, EMS Electro Medical Systems SA, Shenzhen Huikang Medical Apparatus, Storz Medical AG, Allengers Medical Systems, JenaSurgical GmbH, ELMED Medical Systems, Allium Medical Solutions Ltd., Elmed Lithotripsy Systems Inc., Inceler Medikal Co. Ltd.
The urolithiasis management devices market report table of contents includes:
1. Executive Summary
2. Urolithiasis Management Devices Market Characteristics
3. Urolithiasis Management Devices Market Trends And Strategies
4. Urolithiasis Management Devices Market - Macro Economic Scenario
5. Global Urolithiasis Management Devices Market Size and Growth
.
.
.
32. Global Urolithiasis Management Devices Market Competitive Benchmarking
33. Global Urolithiasis Management Devices Market Competitive Dashboard
34. Key Mergers And Acquisitions In The Urolithiasis Management Devices Market
35. Urolithiasis Management Devices Market Future Outlook and Potential Analysis
36. Appendix
Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: info@tbrc.info
Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
Facebook: https://www.facebook.com/TheBusinessResearchCompany
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Blog: https://blog.tbrc.info/
Healthcare Blog: https://healthcareresearchreports.com/
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
Urolithiasis is referred to as kidney stone and is a condition that is characterized by presence of a calculi or a solid piece material in the urinary tract of an individual.
These solid mass commonly known as kidney stone is typically formed in the renal area that is eliminated from the body through the urine stream.The stones that are smaller in size may pass off the body without any symptoms, however, lumps larger than 5 millimeters in size can lead to blockage of the ureter that may cause severe pain in the abdominal area and lower back.
This may result in symptoms that includes pain during urination, vomiting or blood in the urine.
Urolithiasis is caused due to combination of environmental and genetic factors.
It can also be caused due various factors such as obesity, hyperparathyroidism, and high urine calcium levels.Get Exclusive Sample Report @ https://dataintelo.com/request-sample/?reportId=506Rising incidence of chronic kidney diseases is one of the major factors responsible for growth of global urolithiasis management devices market.
Moreover, growth of the urolithiasis management devices market can also be attributed to rising adoption of percutaneous nephrolithotomy (PCNL).Read More @ https://www.marketwatch.com/press-release/urolithiasis-management-devices-market-swot-analysis-cagr-future-insights-growth-by-2026-2019-12-20
